^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Chronic Myelomonocytic Leukemia |
| Drug: | azacitidine (DNMT inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
03/27/2020
Excerpt:
Azacitidine Mylan is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (HSCT) with:...chronic myelomonocytic leukaemia (CMML) with 10 29% marrow blasts without myeloproliferative disorder…
